Back to News
Market Impact: 0.4
Essity Said to Prep for Tissue Exit With Sale, Listing on Table
Source: Bloomberg
M&A & RestructuringShort Interest & ActivismConsumer Demand & Retail
Essity AB is preparing to launch a sale process for its consumer tissue business as soon as next month, following activist investor Cevian Capital's acquisition of a minority stake. The potential divestiture could unlock value and sharpen Essity's portfolio, with the primary market impact likely concentrated in Essity shares and the consumer-products sector.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Grab aims for 'next level' in financial services with purchase of buy-now pay-later platform Atome
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Factbox-Private equity, foreign investors fuel Aussie M&A activity in 2026
- Chinese investors rush into US stocks as Beijing opens wider path overseas
- Is Amazon Stock a Buy After Its Best Quarter in Years?
- Australia’s Reliance Worldwide agrees to Brookfield’s $2.9 billion buyout bid